Clinical Trials in Texas

Showing 8761-8780 of 15,101 trials

Peer Support for Post Intensive Care Syndrome Self-Management

NCT03788096

A prospective, 2-arm, single-blind, randomized controlled clinical feasibility trial design is planned. Forty CCI survivors will be randomized (1:1) to either the PS-PICS (peer support) intervention or usual care (control) group.

Critical IllnessSepsisShock, Septic+5 more

University of Texas at Austin40 participantsStarted Apr 2020

Temple, Texas, United States

COMPLETEDPhase 213 miles

A Study of Pertuzumab in Combination With Trastuzumab Plus an Aromatase Inhibitor in Participants With Metastatic Human Epidermal Growth Factor Receptor 2 (HER2)-Positive and Hormone Receptor-Positive Advanced Breast Cancer

NCT01491737

This randomized, open-label, two-arm, multi-center, Phase II study will evaluate the efficacy and safety of pertuzumab in combination with trastuzumab plus an aromatase inhibitor (AI) in first-line participants with HER2-positive and hormone receptor-positive advanced breast cancer. Participants will be randomized to one of two treatment arms; Arm A (pertuzumab in combination with trastuzumab plus an AI) or Arm B (trastuzumab plus an AI). Participants may also receive induction chemotherapy (a taxane, either docetaxel or paclitaxel) at the investigator's discretion in combination with the assigned treatment arm. The anticipated time on study treatment is until disease progression, unacceptable toxicity, withdrawal of consent, or death whichever occurs first.

Breast Cancer

Hoffmann-La Roche258 participantsStarted Feb 2012

Birmingham, Alabama, United States • Chandler, Arizona, United States • Hot Springs, Arkansas, United States +79 more locations

Peer Support for Post Intensive Care Syndrome Self-Management

A Study of Pertuzumab in Combination With Trastuzumab Plus an Aromatase Inhibitor in Participants With Metastatic Human Epidermal Growth Factor Receptor 2 (HER2)-Positive and Hormone Receptor-Positive Advanced Breast Cancer

Find Trials by Condition in Texas

Sebacia Postmarket Study of Real-World Use

A Study to Assess Safety and Efficacy of KarXT in Adult Patients With Schizophrenia

Study of Intravitreal REGN2176-3 in Participants With Neovascular ("Wet") Age-Related Macular Degeneration (AMD)

A Study of A-101 Topical Solution for the Treatment of Common Warts

A Phase 1-2 Dose-Escalation and Cohort-Expansion Study of Oral Tomivosertib (eFT-508) in Subjects With Hematological Malignancies

The Dystonia Coalition Natural History and Biospecimen Repository for Isolated Dystonias

Topical Rapamycin to Erase Angiofibromas in TSC

A Dose Escalation and Cohort-Expansion Study of Oral eFT508 in Subjects With Advanced Solid Tumors

A Multi-Center Controlled Screening Trial of Safety and Efficacy of Lithium Carbonate in Subjects With Amyotrophic Lateral Sclerosis (ALS)

Clinical Investigation of New CI Delivery Models in an Adult Nucleus CI Population

A Bioequivalence Study With Clinical Endpoints to Evaluate the Safety and Therapeutic Equivalence of Permethrin Cream 5% & Elimite™ in Subjects With Scabies

Randomized Trial of COBRA PzF Stenting to Reduce Duration of Triple Therapy

A Safety and Efficacy Trial of Inhaled Mannitol in Adult Cystic Fibrosis Subjects

Danirixin Dose Ranging Study in Participants With Chronic Obstructive Pulmonary Disease (COPD)

Telehealth Powerful Tools for Caregivers Effectiveness Study

Phase 4, Vedolizumab-4002 Post-marketing, Disease-Drug-Drug Interaction Study

Exploratory Study of Relationships Between Malodor and Urine Metabolomics

A Randomized Phase 2 Study of Ixabepilone Plus Carboplatin and Paclitaxel Plus Carboplatin in Advanced Nonsmall-Cell Lung Cancer